To Evaluate the Efficacy of Mobile Applications in Tailoring and Enhancing Rehabilitation Interventions for Pediatric CP
Launched by SUPERIOR UNIVERSITY · May 20, 2024
Trial Information
Current as of July 06, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how mobile applications can help children with cerebral palsy improve their movement, balance, and coordination. The idea is to use fun games and interactive activities through these apps to support their rehabilitation efforts. The goal is to see if these digital tools can make therapy more effective and enjoyable for kids.
To participate in the trial, children need to be between 5 and 16 years old and have a diagnosis of cerebral palsy. Unfortunately, children with certain health issues, like severe epilepsy or heart problems, or those who have recently received specific treatments, cannot take part. The trial is currently active but not recruiting new participants, meaning they are not looking for more children to join at this time. If eligible, kids would get to use the apps and engage in activities designed to help them improve their skills, making their rehabilitation process more engaging and tailored to their needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with cerebral palsy
- • Children aged between 5 to 16 years
- Exclusion Criteria:
- • Children with unstable epilepsy, chronic heart abnormalities , asthma , anemia and other medical conditions
- • undergone botulinum neurotoxin A (BoNT-A)injections or surgery in the previous 2 months or 6 months respectively. "
About Superior University
Superior University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the university fosters a collaborative environment that brings together multidisciplinary teams of researchers, clinicians, and students. Superior University is focused on exploring novel therapeutic approaches and improving patient outcomes, leveraging its state-of-the-art facilities and cutting-edge technology. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and impact of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, , Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported